Constellation Brands says it will recognize a non-GAAP loss of $38.5 million from its investment in Canopy Growth in the quarter ending Aug. 31.
Tilray shares pop on first contract to deliver medical marijuana in Europe.
Tilray signs a $3.3 million initial supply agreement with a medical cannabis company in Germany.
Is this cannabis name a long-term winner or a one-hit wonder?
Separately, former CEO Bruce Linton says he is still buying shares of the cannabis company.
The cannabis wholesaler for the province of Ontario says that some of the products it has received are non-conforming to its supply agreement with CannTrust.
Canopy Growth reports a quarterly loss of C$1.28 billion.
Canopy Growth could be heading for new lows if longtime support falters. Here's where it's at.
Let's check out the charts and indicators to see if they are growing fast too.